Clinical Trial Update: A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for YM178 in symptomatic overactive bladder (DRAGON) reports that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• YM178

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED